High frequency of telomeric associations in human ovarian surface epithelial cells transformed by human papilloma vital oncogenes

Cancer Genetics and Cytogenetics

Volumn 95, Issue 2, 1997, Pages 166-172

  Wan, Thomas S K ^a   Chan, L C ^a   Ngan, Hextan Y S ^a   Tsao, Sai Wah ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 16; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 22; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; TELOMERE; VIRUS CARCINOGENESIS; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CYTOLOGY; EPITHELIUM CELL; GENETICS; KARYOTYPING; ONCOGENE; OVARY; PAPILLOMA VIRUS; VIRUS CELL TRANSFORMATION;

CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CHROMOSOME ABERRATIONS; EPITHELIAL CELLS; FEMALE; HUMANS; KARYOTYPING; ONCOGENES; OVARY; PAPILLOMAVIRIDAE; TELOMERE;

EID: 0030612664     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00245-2     Document Type: Article

References (27)

1. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC (1988): Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus 12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48:1904-1909.
2. Stoner GD, Kaighn ME, Reddel RR, Resau JH, Bowman D, Naito Z, Matsukura N, You M, Galati AJ, Harris CC (1991): Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res 51:365-371.
3. Kaighn ME, Reddel RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Safiotti U, Harris CC (1989): Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res 49:3050-3056.
4. Band V, Zajchowske D, Kulesa V, Sager R (1990): Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A 87:463-467.
5. Woodworth CD, Bowden PE, Doniger J, Pirisi L, Barnes W, Lancaster WD, DiPaolo JA (1988): Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res 48:4620-4628.
6. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TSK, Chew EC, Muto MG, Knapp RC, Berkowitz RS (1995): Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 218:449-507.
7. Perez-Reyes N, Halbert CL, Smith PP, Benditt EP, McDougall JK (1992): Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci U S A 89:1224-1228.
8. Chan LC, Kwong YL, Liu HW, Chan TK, Todd D, Ching LM (1992): Cytogenetic analysis of hematologic malignancies in Hong Kong. A study of 98 cases. Cancer Genet Cytogenet 62:154-159.
9. Mitelman F ed. (1995): An International System for Human Cytogenetic Nomenclature, S. Karger, Basel.
10. de Lange T (1995): Telomere dynamics and genome instability in human cancer. In: Telomeres. EH Blackburn, CW Greider, eds. Cold Spring Harbor Laboratory Press, New York, pp. 265-293.
11. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus U-M, Furgyik S, Helm G, Himmelmann A, Willen H, Mitelman F (1992): Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosom Cancer 4:58-68.
12. Kiechle-Schwarz M, Bauknecht T, Karck U, Kommoss F, DuBois A, Pfleiderer A (1994): Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas. Gynecol Oncol 55:198-205.
13. Yerganian G, Shein HM, Enders JF (1962): Chromosomal disturbances observed in human fetal renal cells transformed in vitro by simian virus 40 and carried in culture. Cytogenetics 1:314-324.
14. Fitzgerald PH, Morris CM (1984): Telomeric association of chromosomes in B-cell lymphoid leukemia. Hum Genet 67:385-390.
15. Karakousis CP, Dal Cin P, Turc-Carel C, Limon J, Sandberg AA (1987): Chromosomal changes in soft-tissue sarcomas. A new diagnostic parameter. Arch Surg 122:1257-1260.
16. Sawyer JR, Thomas EL, Roloson GJ, Chadduck WM, Boop FA (1992): Telomeric associations evolving to ring chromosomes in a recurrent pleomorphic xanthoastrocytoma. Cancer Genet Cytogenet 60:188-189.
17. Fett-Conte AC, Liedtke Jr H, Chaves H, Thome JA, Tajara EH (1993): Telomeric fusions in a Wilms' tumor. Cancer Genet Cytogenet 69:141-145.
18. Harrison KJ, Neumann E, Kalousek DK, Norman MG, Masui S, Harrison K (1994): Astrocytoma with unique telomeric association. Cancer Genet Cytogenet 76:33-35.
19. Mrozek K, Limon J (1992): High frequency of telomeric associations and chromatid exchanges and breaks in human ovarian carcinoma. Hereditas 117:259-263.
20. Taylor AMR, Oxford JM, Metcalf JA (1981): Spontaneous cytogenetic abnormalities in lymphocytes from thirteen patients with ataxia telangiestasia. Int J Cancer 27:311-319.
21. Kojis TL, Gatti RA, Sparkes RS (1991): The cytogenetics of ataxia telangiectasia. Cancer Genet Cytogenet 56:143-156.
22. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992): Telomere shortening associated with chromosome instability is arrested in immortal cells with express telomerase activity. EMBO J 11:1921-1929.
23. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S (1994): Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68:3410-3414.
24. Saltman D, Morgan R, Cleary ML, de Lange T (1993): Telomeric structure in cells with chromosome end associations. Chromosoma 102:121-128.
25. Blackburn EH (1994): Telomeres: No end in sight. Cell 77:621-623.
26. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Jay JW, Harley CB (1995): Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220:194-200.
27. Harley CB, Villeponteau B (1995): Telomeres and telomerase in aging and cancer. Cur Opin Genet Dev 5:249-255.